Px Wire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. In this issue we survey the year ahead and write about what to watch for in 2016. In our centerspread we update our timeline of biomedical HIV prevention research.
Px Wire January-March 2016, Vol. 9, No. 1
Effectiveness and Adherence in Trials of Oral and Topical Tenofovir-Based Prevention
Trials of oral and topical tenofovir-based PrEP show that these strategies reduce risk of HIV inection if they are used correctly and consistently. Higher adherence is directly linked to greater levels of protection.
Advocating Female Condoms: A reflection on stakeholder commitments & trends in support for female condoms
Produced by the Universal Access to Female Condoms consortium, this document analyzes policies, programs and budgets of organizations working on female condoms; looks at trends in expenditures on female condoms; provides an overview of emerging trends relevant for female condom advocacy, programming and procurement; and formulates recommendations for the future of female condom advocacy.
Anatomy of a Target – VMMC
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at voluntary medical male circumcision.
Anatomy of a Target – PrEP
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at PrEP.
Anatomy of a Target – Treatment
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at antiretroviral therapy and treatment.
Six Things to Know About PrEP
Six things to know about PrEP. For more information on PrEP, visit PrEPWatch.
Anatomy of a Target – Treatment U=U
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at antiretroviral therapy and Treatment U=U.
Anatomy of a Target – PrEP
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at PrEP.
Anatomy of a Target – VMMC
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at VMMC.